Role of a serum‐based biomarker panel in the early diagnosis of lung cancer for a cohort of high‐risk patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|S17|3113-3121

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.S17, 2015-09, pp. : 3113-3121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Probability of cancer in high‐risk patients predicted by the protein‐based lung cancer biomarker panel in China: LCBP study

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 262-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients

By  

Pancreatology, Vol. 1, Iss. 5, 2001-09 ,pp. : 486-509

Karger

Access to resources Recommend Favorite

Increased risk of lung cancer in patients with eczema: a nationwide cohort study in Taiwan

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 14, Iss. 9, 2016-09 ,pp. : 924-931

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potentially malignant oral disorders and high‐risk habits in liver cirrhosis and lung cancer patients

By  

ORAL DISEASES, Vol. 21, Iss. 3, 2015-04 ,pp. : 373-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving the diagnosis and treatment of high‐risk localised or locally advanced prostate cancer

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 1, 2015-01 ,pp. : 26-30

John Wiley & Sons Inc

Access to resources Recommend Favorite